12 Share Information CSL Limited Issued Capital Ordinary Shares: 481,706,266 as at 30 June 2022; 481,706,266 as at 11 August 2022. Details of incorporation CSL’s activities were carried on within the Commonwealth Department of Health until the Commonwealth Serum Laboratories Commission was formed as a Statutory Act 1961 (Cth) (the CSL Act) on 2 November 1961. On 1 April 1991, the Corporation was converted to a public company limited by shares under the Corporations Law of the Australian Capital Territory and it was renamed Commonwealth Serum Laboratories Limited. These changes were brought into effect by the Commonwealth Serum Laboratories (Conversion into Public Company) Act 1990 (Cth). On 7 October 1991, the name was changed to CSL Limited. The Commonwealth divested all of its shares by public float on 3 June 1994. The CSL Sale Act 1993 (Cth) amends the CSL Act to impose certain restrictions on the voting rights of persons having significant foreign shareholdings, and certain restrictions on CSL itself. CSL ordinary shares (being the only class of shares on issue) have been traded on the Australian Securities Exchange (ASX) since 30 May 1994. Melbourne is the Home Exchange. In June 2014, CSL commenced a sponsored Level 1 American Depository Receipts (ADR) programwith the Bank of New York Mellon. The sponsored ADR program replaced the unsponsored ADR programs that have previously operated with CSL’s involvement. The ADRs are tradeable via licensed US brokers in the ordinary course of trading in the Over-the-Counter (OTC) market in the US. Particulars for the sponsored ADR program are: US Exchange – OTC and DR Ticker Symbol – CSLLY. On 14 February 2022 CSL announced that it had completed a Share Purchase Plan raising A$750 million (US$534 million). Substantial shareholders The following table shows holdings of 5% or more of voting rights in CSL Limited’s shares as notified to CSL Limited under the Australian Corporations Act 2001 (Cth), Section 671B as at 30 June 2022. Date of last notice Title of class Identity of person or group Date received Date of change Number owned Ordinary Shares Blackrock Group 2 December 2019 28 November 2019 27,353,205 For the period between 1 July 2022 and 11 August 2022, the following table shows holdings of 5% or more of voting rights in CSL Limited’s shares, as notified to CSL Limited under the Australian Corporations Act 2001 (Cth), Section 671B. Date of last notice Title of class Identity of person or group Date received Date of change Number owned Ordinary Shares State Street Group 22 July 2022 20 July 2022 24,324,468 CSL Limited Annual Report 2021/22 147
RkJQdWJsaXNoZXIy MjE2NDg3